Results 141 to 150 of about 41,602 (220)

A comorbidity of ulcerative colitis, ankylosing spondylitis, Takayasu's arteritis and silent thyroiditis: an extensive case-based review. [PDF]

Ann Med Surg (Lond)
Ghabally M, Roumieh G, Qadabashi K, Dayekh J, Baydoun E, Jondiah Y, Shami B, Jriekh Z.   +7 more
europepmc   +1 more source

Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis. [PDF]

Ann Rheum Dis
Fang C, Du L, Gao S, Chen Y, Chen Z, Wu Z, Li L, Li J, Zeng X, Li M, Li Y, Tian X.   +11 more
europepmc   +1 more source

Takayasu arteritis

, 2020
openaire   +1 more source

Early diagnosis and standardized treatment are critical to improve the prognosis of patients with Takayasu's arteritis. [PDF]

Rheumatol Immunol Res
Tian X, Zeng X.
europepmc   +1 more source

What is new in imaging to assist in the diagnosis of giant cell arteritis and Takayasu's arteritis since the EULAR and ACR/VF recommendations? [PDF]

Front Med (Lausanne)
Ni R, Kohler MJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Updates in the diagnosis and management of Takayasu’s arteritis

Postgraduate medicine, 2023
Takayasu’s arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. Early diagnosis is important to prevent serious end organ damage, including to stroke and ischemic heart disease.
A. Somashekar, Y. T. Leung
semanticscholar   +1 more source

Takayasu's arteritis

The Lancet, 2000
Correspondence to: Dr Fujio Numano (e-mail: numano.med3@tmd.ac.jp) stenotic lesions or thrombus formation. More acute progression causes destruction of the media of the arterial wall, leading to the formation of aneurysms or rupture of the involved arteries.
F, Numano, M, Okawara, H, Inomata, Y, Kobayashi   +3 more
openaire   +4 more sources

Patterns of clinical presentation in Takayasu's arteritis.

Seminars in Arthritis & Rheumatism, 2020
OBJECTIVE Takayasu's arteritis (TAK) is a clinically heterogenous disease. Patterns of clinical presentation in TAK at diagnosis have not been well described, and a "triphasic pattern" of constitutional symptoms evolving into vascular inflammation and ...
K. Quinn, K. Quinn, K. Gribbons, S. Carette, D. Cuthbertson, N. Khalidi, C. Koening, C. Langford, Carol A. McAlear, P. Monach, L. Moreland, C. Pagnoux, P. Seo, A. Sreih, K. Warrington, S. Ytterberg, Elaine Novakovich, P. Merkel, P. Grayson   +18 more
semanticscholar   +1 more source

Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab.

Seminars in Arthritis & Rheumatism, 2021
OBJECTIVE To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients with Takayasu arteritis. METHODS Takayasu arteritis patients who were refractory to conventional immunosuppressive (IS) drugs and received biologic ...
F. Alibaz-Oner, S. Kaymaz-Tahra, Ö. Bayındır, A. Yazıcı, B. Ince, K. Kalkan, N. Kanıtez, S. Kocaer, N. Y. Yasar Bilge, A. Omma, Elif Durak, C. Ilgın, S. Akar, T. Kaşifoğlu, F. Önen, H. Emmungil, M. Inanç, A. Çefle, K. Aksu, G. Keser, H. Direşkeneli   +20 more
semanticscholar   +1 more source

Takayasu’s arteritis

Current Treatment Options in Cardiovascular Medicine, 2008
Takayasu's arteritis is a rare disease that causes arterial inflammation with resulting stenosis or aneurysm of affected vessels. It primarily affects young females and has a predilection for the aorta, its primary branches, and the pulmonary arteries.
Curry L, Koening, Carol A, Langford
openaire   +2 more sources